News

Oxford Spin-out ReOx Ltd to Develop New Drug Therapies

30th August 2003

All News | Spinouts & Startups | Technology News

Isis' latest spin-out company, ReOx Ltd, is set to develop potential therapies for a huge range of diseases, from heart disease to stroke, using world-leading expertise in biology and chemistry. The company was spun out this summer and has raised £2 million in capital investment.

OxLoc Ltd Completes Trans-European Pilot

30th August 2003

All News | Spinouts & Startups | Technology News

OxLoc Ltd, a spin-out company from the University of Oxford, has announced their first successful pilot study within the rail freight industry.

Optisol™ – New Product from Oxonica

30th May 2003

All News | Spinouts & Startups | Technology News

A new product concept in UV protection and anti-ageing for sunscreens and cosmetics

NaturalMotion Will Revolutionise Computer Animation

5th May 2003

All News | Spinouts & Startups | Technology News

NaturalMotion Ltd, which combines biology with computer science to create realistic and interactive character animation for games, films and simulations, has been launched as Oxford University's newest spin-out company.

Oxford ArchDigital Archaeology

10th April 2003

All News | Spinouts & Startups | Technology News

Oxford ArchDigital Archaeology, a spin-out company from the University of Oxford, has been chosen to deliver the new Finds Management Software for the Portable Antiquities Scheme.

Oxford Technology Transfer

30th March 2003

All News | Spinouts & Startups | Technology News

Oxford Business Alumni News Bulletin.

VASTox: First Spin-out of 2003

30th March 2003

All News | Spinouts & Startups | Technology News

VASTox Ltd, Isis' first spin-out company of 2003, was launched in February from the University of Oxford's Chemistry Department.

InhibOx Drug Discovery Launched in Oxford

1st February 2003

All News | Spinouts & Startups | Technology News

Oxford University's latest spin-out is the drug-discovery company InhibOx Ltd, which uses advanced computational methods to carry out in silico screening on a massive scale to discover new leads for drugs quickly and cost-effectively. Initial projects are focused on cancer research, though other indications will be added in due course.

Oxford Risk – What Businesses Can Learn from Animals

1st January 2003

All News | Spinouts & Startups | Technology News

Oxford Risk Research and Analysis (ORRA), a new spin-out company founded by Oxford University zoologists, has been created to provide services to businesses who are making decisions related to risks. Intriguingly, among the useful insights into risk management are those gained from studies on animal behaviour.

Oxford Immunotec; Revolutionary new tuberculosis test

30th November 2002

All News | Spinouts & Startups | Technology News

A revolutionary new test for identifying people infected with tuberculosis (TB), one of the leading causes of death worldwide, will shortly be launched by Oxford Immunotec Ltd, a new spin-out company from the University of Oxford. The test radically improves the speed and accuracy with which the disease can be identified. It has been developed to replace the existing skin test for TB, which is given to 600,000 UK schoolchildren every year.

News

Ready to get in touch?